HOME >> MEDICINE >> NEWS
Asthmatx completes enrollment in pivotal study of bronchial thermoplasty

San Francisco, CA, May 21, 2007 Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma, announced today the successful completion of enrollment in its pivotal FDA approved IDE study, the Asthma Intervention Research 2 (AIR2) Trial of the Alair Bronchial Thermoplasty System. Bronchial Thermoplasty is a non-drug treatment for asthma under clinical investigation in the United States. The minimally invasive, bronchoscopic procedure uses thermal energy to reduce the airway smooth muscle responsible for constriction in asthma patients.

Leading asthma and bronchoscopy experts are participating in this international, multicenter AIR2 Trial to establish the safety and efficacy of the Alair System. Nearly 300 patients were enrolled in the study during the last 18 months at over 30 world-renowned medical centers including 15 US research hospitals. The AIR2 Trial is the fourth clinical study of the Alair Bronchial Thermoplasty System. To date, over 700 bronchoscopic procedures have been performed on asthma patients.

"We are very pleased to be a participant in this very important AIR2 Trial, the success of which will result in an important advancement in the treatment of severe asthma," states Mario Castro, MD, Associate Professor at the Washington University School of Medicine and Asthma Center, and a Principal Investigator in the AIR2 Trial. "As the lead enrolling center in the United States, we have experienced significant patient interest in bronchial thermoplasty, which we hope may become a new option for patients with difficult-to-treat asthma."

Final results of the first randomized and controlled clinical study of bronchial thermoplasty, the Asthma Intervention Research (AIR) Trial, were also reported today at the annual scientific assembly of the American Thoracic Society (ATS) by Gerard Cox, MB, Professor of Medicine, McMaster University, Canada, and principal investigato
'"/>

Contact: Meghan Oreste
moreste@comcast.net
617-823-1441
Asthmatx
21-May-2007


Page: 1 2

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. MacroChem completes patient enrollment for Phase II trial of EcoNail for treatment of onychomycosis
3. GroPep completes final milestone of the path malaria vaccine initiative
4. Im a Kid Too project completes first phase
5. Approval to start US BTT pivotal trial
6. Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM
7. New data show CAS in clinical practice has comparable MAE rate with pivotal sapphire trial
8. Now is a pivotal point in history to abolish state execution
9. Orqis Medical receives unconditional FDA approval for pivotal trial of percutaneous CHF therapy
10. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
11. Penn study finds pro-death proteins required to regulate healthy immune function

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... ... 11, 2019 , ... Executives at health systems and hospitals across America are ... over the past several years has been intense. For professionals and organizations that struggle ... America will depend largely on how these executives respond. Will they have the tools ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... facing the ever-changing corporate landscape, Mediaplanet today announces the launch of its ... topics ranging from the importance of candid one-on-one conversations, ideas for improving ...
(Date:9/9/2019)... ... September 09, 2019 , ... ... Dentistry in Cornelius, NC, now welcome individuals with tooth loss in Davidson, NC ... with patients who have single or multiple missing teeth and want the advantages ...
(Date:9/9/2019)... ... September 09, 2019 , ... On September 6, 2019, ... on a diabetes-language movement (#LanguageMatters) to include oral and written language. The organization ... stigma, respectful and inclusive, empowering, and person-centered (to include care that is respectful ...
(Date:9/8/2019)... ... 2019 , ... The Southern Illinois University Edwardsville School of ... reached an all-time high with 1,778 students. , The SON’s enrollment features ... students. The total does not include an additional 30 undeclared graduate students, who ...
Breaking Medicine News(10 mins):
(Date:9/14/2019)... ... 14, 2019 , ... On September 11, 2019, after a ... in Middlesex County found Johnson & Johnson liable for causing the Plaintiffs’ cancers. ... by asbestos-containing J&J talc products. , A unanimous jury found that ...
(Date:9/12/2019)... ... September 12, 2019 , ... iPatientCare, a ... practice management, and patient engagement solutions, announced today the participation of Amazon ... (NUCON) 2019 . The annual conference features informative sessions about upcoming enhancements, ...
(Date:9/11/2019)... ... September 12, 2019 , ... Understanding the Drug ... FDAnews Webinar, Thursday, Sept. 26, 2019, 1:30-3:00 p.m. EDT, https://www.fdanews.com/understanding-the-dscsa , ... Is the company clear on nuances of the guidelines regulating the drug supply ...
Breaking Medicine Technology:
Cached News: